Abstract
Patients with succinyl-CoA:3-oxoacid CoA transferase (SCOT) deficiency and 3-hydroxy-3-methylglutaryl (HMG)-CoA lyase deficiency are at increased risk of developing metabolic acidosis and hypoglycemia during pregnancy, delivery, and postpartum period. This can be fatal if not treated appropriately. Pregnancy in such patients should be managed in a specialist center by a multidisciplinary team including metabolic physician, high-risk obstetrician, and metabolic dietician. We report two pregnancies in women with SCOT deficiency and HMG-CoA lyase deficiency, which were successfully managed at this tertiary care center. The patient with SCOT deficiency had recurrent ketoacidosis due to severe nausea and vomiting requiring several hospital admissions during pregnancy, while the patient with HMG-CoA lyase deficiency remained metabolically stable. Both patients, nevertheless, had normal delivery of live-born infants and had uneventful postpartum period.
References
Alfadhel M, Al Othaim A, Al Saif S et al (2017) Expanded newborn screening program in Saudi Arabia: incidence of screened disorders. J Paediatr Child Health. doi:10.1111/jpc.13469
Frise CJ, Mackillop L, Joash K et al (2013) Starvation ketoacidosis in pregnancy. Eur J Obstet Gynecol Reprod Biol 167(1):1–7
Fukao T, Mitchell G, Sass JO et al (2014) Ketone body metabolism and its defects. J Inherit Metab Dis 37:541–551
Langendonk JG, Roos JCP, Angus L et al (2012) A series of pregnancies in women with inherited metabolic disease. J Inherit Metab Dis 35:419–424
Merron S, Akhtar R (2009) Management and communication problems in a patient with succinyl-CoA transferase deficiency in pregnancy and labour. Int J Obstet Anesth 18(3):280–283
Metzger BE, Ravnikar V, Vileisis RA et al (1982) “Accelerated starvation” and the skipped breakfast in late normal pregnancy. Lancet 1:588–592
Ozand PT, Al Aqeel A, Gascon G et al (1991) 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis 14(2):174–188
Pipitone A, Raval DB, Duis J et al (2016) The management of pregnancy and delivery in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Am J Med Genet A 170(6):1600–1602
Acknowledgments
We are thankful to Eman Megdad, Dana AlQasaby, and all the physicians for their contribution in the management of these patients.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Avihu Boneh, MD, PhD, FRACP
Appendices
Synopsis
Successful management of pregnancy and delivery in these patients includes multidisciplinary approach with maintenance of adequate caloric and protein intake, hydration, electrolyte balance, and minimizing physiological stress.
Details of the Contributions of Individual Authors
RAS, MN, and ZNH devised the prenatal and perinatal management protocol.
RAS participated in the management of both patients, planned, and wrote the manuscript.
ZNH, MN, RK, BSH, and MA participated in the management of patients and contributed to the manuscript.
Corresponding Author: Raashda A. Sulaiman.
Guarantor: Zuhair N. Al-Hassnan.
RAS, MN, RK, BSH, MA, and ZNH declare that they do not have any competing interest.
No funding was required for this report.
Informed consent has been taken from the patients.
Rights and permissions
Copyright information
© 2017 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sulaiman, R.A., Al-Nemer, M., Khan, R., Almasned, M., Handoum, B.S., Al-Hassnan, Z.N. (2017). Successful Management of Pregnancies in Patients with Inherited Disorders of Ketone Body Metabolism. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 38. JIMD Reports, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2017_24
Download citation
DOI: https://doi.org/10.1007/8904_2017_24
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56609-1
Online ISBN: 978-3-662-56610-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)